Audit 37317

FY End
2022-12-31
Total Expended
$1.90M
Findings
0
Programs
9
Year: 2022 Accepted: 2023-06-25
Auditor: Jm&m

Organization Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
JXPVN9BZLZ15 Felix Oliver Auditee
2024626820 Tina Peacher Auditor
No contacts on file

Notes to SEFA

Accounting Policies: NOTE A BASIS OF PRESENTATIONThe accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the federal grant activity of Institute for Clinical Research, Inc. (ICR) under programs of the federal government for the year ended December 31, 2022. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of ICR, it is not intended to and does not present the financial position, changes in net assets, or cash flows of ICR.NOTE B SUMMARY OF SIGNIFICANT ACCOUNTING POLICIESExpenditures reported in the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein, certain types of expenses are not allowable or are limited to reimbursement. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate.